Hehlmann, R., & Lauseker, M. (2024). How to individualize therapy after failing milestones in chronic myeloid leukaemia: Weighting late response and early death from CML against risk of alternative therapies. Leukemia, 38(2), . https://doi.org/10.1038/s41375-024-02139-4
Chicago-Zitierstil (17. Ausg.)Hehlmann, Rüdiger, und Michael Lauseker. "How to Individualize Therapy After Failing Milestones in Chronic Myeloid Leukaemia: Weighting Late Response and Early Death from CML Against Risk of Alternative Therapies." Leukemia 38, no. 2 (2024). https://doi.org/10.1038/s41375-024-02139-4.
MLA-Zitierstil (9. Ausg.)Hehlmann, Rüdiger, und Michael Lauseker. "How to Individualize Therapy After Failing Milestones in Chronic Myeloid Leukaemia: Weighting Late Response and Early Death from CML Against Risk of Alternative Therapies." Leukemia, vol. 38, no. 2, 2024, https://doi.org/10.1038/s41375-024-02139-4.